Sangamo Therapeutics Stock Volatility
| SGMO Stock | USD 0.51 0.02 4.08% |
Sangamo Therapeutics appears to be abnormally volatile, given 3 months investment horizon. Sangamo Therapeutics owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.0728, which indicates the firm had a 0.0728% return per unit of risk over the last 3 months. By inspecting Sangamo Therapeutics' technical indicators, you can evaluate if the expected return of 0.84% is justified by implied risk. Please review Sangamo Therapeutics' Risk Adjusted Performance of 0.0527, semi deviation of 7.91, and Coefficient Of Variation of 1413.45 to confirm if our risk estimates are consistent with your expectations. Key indicators related to Sangamo Therapeutics' volatility include:
30 Days Market Risk | Chance Of Distress | 30 Days Economic Sensitivity |
Sangamo Therapeutics Stock volatility depicts how high the prices fluctuate around the mean (or its average) price. In other words, it is a statistical measure of the distribution of Sangamo daily returns, and it is calculated using variance and standard deviation. We also use Sangamo's beta, its sensitivity to the market, as well as its odds of financial distress to provide a more practical estimation of Sangamo Therapeutics volatility.
Sangamo |
Since volatility provides investors with entry points to take advantage of stock prices, companies, such as Sangamo Therapeutics can benefit from it. Downward market volatility can be a perfect environment for investors who play the long game. Here, they may decide to buy additional stocks of Sangamo Therapeutics at lower prices. For example, an investor can purchase Sangamo stock that has halved in price over a short period. This will lower your average cost per share, thereby improving your portfolio's performance when the markets normalize. Similarly, when the prices of Sangamo Therapeutics' stock rises, investors can sell out and invest the proceeds in other equities with better opportunities. Investing when markets are volatile with better valuations will accord both investors and companies the opportunity to generate better long-term returns.
Moving together with Sangamo Stock
| 0.76 | EGRX | Eagle Pharmaceuticals | PairCorr |
| 0.81 | RDY | Dr Reddys Laboratories Financial Report 8th of May 2024 | PairCorr |
Sangamo Therapeutics Market Sensitivity And Downside Risk
Sangamo Therapeutics' beta coefficient measures the volatility of Sangamo stock compared to the systematic risk of the entire market represented by your selected benchmark. In mathematical terms, beta represents the slope of the line through a regression of data points where each of these points represents Sangamo stock's returns against your selected market. In other words, Sangamo Therapeutics's beta of 5.57 provides an investor with an approximation of how much risk Sangamo Therapeutics stock can potentially add to one of your existing portfolios. Sangamo Therapeutics is displaying above-average volatility over the selected time horizon. Sangamo Therapeutics is a potential penny stock. Although Sangamo Therapeutics may be in fact a good instrument to invest, many penny stocks are speculative in nature and are subject to artificial price hype. Please make sure you totally understand the upside potential and downside risk of investing in Sangamo Therapeutics. We encourage investors to look for signals such as email spams, message board hypes, claims of breakthroughs, volume upswings, sudden news releases, promotions that are not reported, or demotions released before SEC filings. Please also check biographies and work history of current and past company officers before investing in high volatility instruments, penny stocks, or equities with microcap classification. You can indeed make money on Sangamo instrument if you perfectly time your entry and exit. However, remember that penny stocks that have been the subject of artificial hype usually unable to maintain their increased share price for more than just a few days. The price of a promoted high volatility instrument will almost always revert back. The only way to increase shareholder value is through legitimate performance backed up by solid fundamentals.
3 Months Beta |Analyze Sangamo Therapeutics Demand TrendCheck current 90 days Sangamo Therapeutics correlation with market (NYSE Composite)Sangamo Beta |
Sangamo standard deviation measures the daily dispersion of prices over your selected time horizon relative to its mean. A typical volatile entity has a high standard deviation, while the deviation of a stable instrument is usually low. As a downside, the standard deviation calculates all uncertainty as risk, even when it is in your favor, such as above-average returns.
Standard Deviation | 11.51 |
It is essential to understand the difference between upside risk (as represented by Sangamo Therapeutics's standard deviation) and the downside risk, which can be measured by semi-deviation or downside deviation of Sangamo Therapeutics' daily returns or price. Since the actual investment returns on holding a position in sangamo stock tend to have a non-normal distribution, there will be different probabilities for losses than for gains. The likelihood of losses is reflected in the downside risk of an investment in Sangamo Therapeutics.
Using Sangamo Put Option to Manage Risk
Put options written on Sangamo Therapeutics grant holders of the option the right to sell a specified amount of Sangamo Therapeutics at a specified price within a specified time frame. The put buyer has a limited loss and, while not fully unlimited gains, as the price of Sangamo Stock cannot fall below zero, the put buyer does gain as the price drops. So, one way investors can hedge Sangamo Therapeutics' position is by buying a put option against it. The put option used this way is usually referred to as insurance. If an undesired outcome occurs and loss on holding Sangamo Therapeutics will be realized, the loss incurred will be offset by the profits made with the option trade.
Sangamo Therapeutics' PUT expiring on 2024-05-17
Profit |
| Sangamo Therapeutics Price At Expiration |
Current Sangamo Therapeutics Insurance Chain
| Delta | Gamma | Open Int | Expiration | Current Spread | Last Price | |||
Put | 2024-05-17 PUT at $2.0 | -0.5858 | 0.5281 | 7 | 2024-05-17 | 1.3 - 1.9 | 1.52 | View |
Put | 2024-05-17 PUT at $1.5 | -0.5702 | 0.5926 | 5 | 2024-05-17 | 0.75 - 1.45 | 0.65 | View |
Put | 2024-05-17 PUT at $1.0 | -0.6609 | 0.8822 | 1150 | 2024-05-17 | 0.05 - 0.55 | 0.55 | View |
Sangamo Therapeutics Stock Volatility Analysis
Volatility refers to the frequency at which Sangamo Therapeutics stock price increases or decreases within a specified period. These fluctuations usually indicate the level of risk that's associated with Sangamo Therapeutics' price changes. Investors will then calculate the volatility of Sangamo Therapeutics' stock to predict their future moves. A stock that has erratic price changes quickly hits new highs, and lows are considered highly volatile. A stock with relatively stable price changes has low volatility. A highly volatile stock is riskier, but the risk cuts both ways. Investing in highly volatile security can either be highly successful, or you may experience significant failure. There are two main types of Sangamo Therapeutics' volatility:
Historical Volatility
This type of stock volatility measures Sangamo Therapeutics' fluctuations based on previous trends. It's commonly used to predict Sangamo Therapeutics' future behavior based on its past. However, it cannot conclusively determine the future direction of the stock.Implied Volatility
This type of volatility provides a positive outlook on future price fluctuations for Sangamo Therapeutics' current market price. This means that the stock will return to its initially predicted market price. This type of volatility can be derived from derivative instruments written on Sangamo Therapeutics' to be redeemed at a future date.Transformation |
The output start index for this execution was zero with a total number of output elements of sixty-one. Sangamo Therapeutics Average Price is the average of the sum of open, high, low and close daily prices of a bar. It can be used to smooth an indicator that normally takes just the closing price as input.
Sangamo Therapeutics Projected Return Density Against Market
Given the investment horizon of 90 days the stock has the beta coefficient of 5.5738 . This usually implies as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Sangamo Therapeutics will likely underperform.Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Sangamo Therapeutics or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Sangamo Therapeutics' price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Sangamo stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
Sangamo Therapeutics has an alpha of 0.3614, implying that it can generate a 0.36 percent excess return over NYSE Composite after adjusting for the inherited market risk (beta). Predicted Return Density |
| Returns |
What Drives a Sangamo Therapeutics Price Volatility?
Several factors can influence a stock's market volatility:Industry
Specific events can influence volatility within a particular industry. For instance, a significant weather upheaval in a crucial oil-production site may cause oil prices to increase in the oil sector. The direct result will be the rise in the stock price of oil distribution companies. Similarly, any government regulation in a specific industry could negatively influence stock prices due to increased regulations on compliance that may impact the company's future earnings and growth.Political and Economic environment
When governments make significant decisions regarding trade agreements, policies, and legislation regarding specific industries, they will influence stock prices. Everything from speeches to elections may influence investors, who can directly influence the stock prices in any particular industry. The prevailing economic situation also plays a significant role in stock prices. When the economy is doing well, investors will have a positive reaction and hence, better stock prices and vice versa.The Company's Performance
Sometimes volatility will only affect an individual company. For example, a revolutionary product launch or strong earnings report may attract many investors to purchase the company. This positive attention will raise the company's stock price. In contrast, product recalls and data breaches may negatively influence a company's stock prices.Sangamo Therapeutics Stock Risk Measures
Given the investment horizon of 90 days the coefficient of variation of Sangamo Therapeutics is 1372.93. The daily returns are distributed with a variance of 132.45 and standard deviation of 11.51. The mean deviation of Sangamo Therapeutics is currently at 7.75. For similar time horizon, the selected benchmark (NYSE Composite) has volatility of 0.61
α | Alpha over NYSE Composite | 0.36 | |
β | Beta against NYSE Composite | 5.57 | |
σ | Overall volatility | 11.51 | |
Ir | Information ratio | 0.06 |
Sangamo Therapeutics Stock Return Volatility
Sangamo Therapeutics historical daily return volatility represents how much of Sangamo Therapeutics stock's daily returns swing around its mean - it is a statistical measure of its dispersion of returns. The firm inherits 11.5085% risk (volatility on return distribution) over the 90 days horizon. By contrast, NYSE Composite accepts 0.6294% volatility on return distribution over the 90 days horizon. Performance |
| Timeline |
About Sangamo Therapeutics Volatility
Volatility is a rate at which the price of Sangamo Therapeutics or any other equity instrument increases or decreases for a given set of returns. It is measured by calculating the standard deviation of the annualized returns over a given period of time and shows the range to which the price of Sangamo Therapeutics may increase or decrease. In other words, similar to Sangamo's beta indicator, it measures the risk of Sangamo Therapeutics and helps estimate the fluctuations that may happen in a short period of time. So if prices of Sangamo Therapeutics fluctuate rapidly in a short time span, it is termed to have high volatility, and if it swings slowly in a more extended period, it is understood to have low volatility.
Please read more on our technical analysis page.| Last Reported | Projected for Next Year | ||
| Selling And Marketing Expenses | 26.8 M | 28.1 M | |
| Market Cap | 85.3 M | 81 M |
Sangamo Therapeutics' stock volatility refers to the amount of uncertainty or risk involved with the size of changes in its stock's price. It is a statistical measure of the dispersion of returns on Sangamo Stock over a specified period of time, often expressed as the standard deviation of daily returns. In other words, it measures how much Sangamo Therapeutics' price varies over time.
3 ways to utilize Sangamo Therapeutics' volatility to invest better
Higher Sangamo Therapeutics' stock volatility means that the price of its stock is changing rapidly and unpredictably, while lower stock volatility indicates that the price of Sangamo Therapeutics stock is relatively stable. Investors and traders use stock volatility as an indicator of risk and potential reward, as stocks with higher volatility can offer the potential for more significant returns but also come with a greater risk of losses. Sangamo Therapeutics stock volatility can provide helpful information for making investment decisions in the following ways:- Measuring Risk: Volatility can be used as a measure of risk, which can help you determine the potential fluctuations in the value of Sangamo Therapeutics investment. A higher volatility means higher risk and potentially larger changes in value.
- Identifying Opportunities: High volatility in Sangamo Therapeutics' stock can indicate that there is potential for significant price movements, either up or down, which could present investment opportunities.
- Diversification: Understanding how the volatility of Sangamo Therapeutics' stock relates to your other investments can help you create a well-diversified portfolio of assets with varying levels of risk.
Sangamo Therapeutics Investment Opportunity
Sangamo Therapeutics has a volatility of 11.51 and is 18.27 times more volatile than NYSE Composite. 96 percent of all equities and portfolios are less risky than Sangamo Therapeutics. You can use Sangamo Therapeutics to enhance the returns of your portfolios. The stock experiences a very speculative upward sentiment. Check odds of Sangamo Therapeutics to be traded at $0.6375 in 90 days.Weak diversification
The correlation between Sangamo Therapeutics and NYA is 0.3 (i.e., Weak diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Sangamo Therapeutics and NYA in the same portfolio, assuming nothing else is changed.
Sangamo Therapeutics Additional Risk Indicators
The analysis of Sangamo Therapeutics' secondary risk indicators is one of the essential steps in making a buy or sell decision. The process involves identifying the amount of risk involved in Sangamo Therapeutics' investment and either accepting that risk or mitigating it. Along with some common measures of Sangamo Therapeutics stock's risk such as standard deviation, beta, or value at risk, we also provide a set of secondary indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Risk Adjusted Performance | 0.0527 | |||
| Market Risk Adjusted Performance | 0.1502 | |||
| Mean Deviation | 7.48 | |||
| Semi Deviation | 7.91 | |||
| Downside Deviation | 8.43 | |||
| Coefficient Of Variation | 1413.45 | |||
| Standard Deviation | 11.19 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential stocks, we recommend comparing similar stocks with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Sangamo Therapeutics Suggested Diversification Pairs
Pair trading is one of the very effective strategies used by professional day traders and hedge funds capitalizing on short-time and mid-term market inefficiencies. The approach is based on the fact that the ratio of prices of two correlating shares is long-term stable and oscillates around the average value. If the correlation ratio comes outside the common area, you can speculate with a high success rate that the ratio will return to the mean value and collect a profit.
The effect of pair diversification on risk is to reduce it, but we should note this doesn't apply to all risk types. When we trade pairs against Sangamo Therapeutics as a counterpart, there is always some inherent risk that will never be diversified away no matter what. This volatility limits the effect of tactical diversification using pair trading. Sangamo Therapeutics' systematic risk is the inherent uncertainty of the entire market, and therefore cannot be mitigated even by pair-trading it against the equity that is not highly correlated to it. On the other hand, Sangamo Therapeutics' unsystematic risk describes the types of risk that we can protect against, at least to some degree, by selecting a matching pair that is not perfectly correlated to Sangamo Therapeutics.
When determining whether Sangamo Therapeutics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Sangamo Therapeutics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Sangamo Therapeutics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Sangamo Therapeutics Stock: Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Sangamo Therapeutics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in population. To learn how to invest in Sangamo Stock, please use our How to Invest in Sangamo Therapeutics guide.You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.
Complementary Tools for Sangamo Stock analysis
When running Sangamo Therapeutics' price analysis, check to measure Sangamo Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sangamo Therapeutics is operating at the current time. Most of Sangamo Therapeutics' value examination focuses on studying past and present price action to predict the probability of Sangamo Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sangamo Therapeutics' price. Additionally, you may evaluate how the addition of Sangamo Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated |
Is Sangamo Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Sangamo Therapeutics. If investors know Sangamo will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Sangamo Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.48) | Revenue Per Share 1.01 | Quarterly Revenue Growth (0.93) | Return On Assets (0.18) | Return On Equity (1.36) |
The market value of Sangamo Therapeutics is measured differently than its book value, which is the value of Sangamo that is recorded on the company's balance sheet. Investors also form their own opinion of Sangamo Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Sangamo Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Sangamo Therapeutics' market value can be influenced by many factors that don't directly affect Sangamo Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Sangamo Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Sangamo Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Sangamo Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.